Baharin, Lemen .
HRN: 26-72-78 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/19/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
02/19/2025
02/26/2025
IV
600mg
Q6hrs
T/C Perinephric Abscess
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes